Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Hyperfine, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HYPR: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders3642+6
Shares17.7M17.8M+71.3K (+0.4%)
Value$62.5M$40.2M−$22.3M (−35.7%)

New holders (10)

Institutions that held Hyperfine, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HYPR in Q2 2022
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC150,000$335.0K0.01%
Jane Street Group, LLC72,272$161.0K0.00%
HRT Financial LP46,613$103.0K0.00%
Susquehanna International Group, LLP31,958$71.0K0.00%
Goldman Sachs Group Inc20,651$46.0K0.00%
Millennium Management LLC18,396$41.0K0.00%
Tower Research Capital LLC (TRC)15,426$34.0K0.00%
Squarepoint Ops LLC13,958$31.0K0.00%
Rockefeller Capital Management L.P.3,000$6.00K0.00%
Advisor Group Holdings, Inc.2,403$5.00K0.00%

Sold out (4)

Institutions that held Hyperfine, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HYPR in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Affinity Asset Advisors, LLC76,162$270.0K
Qube Research & Technologies Ltd18,499$65.0K
Bank of America Corp713$3.00K
Royal Bank of Canada100$0